Safety and efficacy of brivaracetam in children epilepsy: a systematic review and meta-analysis

Author:

Song Ting,Feng Lingjun,Xia Yulei,Pang Meng,Geng Jianhong,Zhang Xiaojun,Wang Yanqiang

Abstract

BackgroundEpilepsy is one of the most common neurological diseases, affecting people of any age. Although the treatments of epilepsy are more and more diverse, the uncertainty regarding efficacy and adverse events still exists, especially in the control of childhood epilepsy.MethodsWe performed a systematic review and meta- analysis following the Cochrane Handbook and preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Four databases including PubMed, Embase, Web of Science and Cochrane library were searched. Studies reporting the use of brivaracetam monotherapy or adjuvant therapy in children (aged ≤18 years) were eligible for inclusion. Each stage of the review was conducted by two authors independently. Random-effects models were used to combine effect sizes for the estimation of efficacy and safety.ResultsA total of 1884 articles were retrieved, and finally 9 articles were included, enrolling 503 children with epilepsy. The retention rate of BRV treatment was 78% (95% CI: 0.64–0.91), the responder rate (reduction of seizure frequency ≥ 50%) was 35% (95% CI: 0.24–0.47), the freedom seizure rate (no seizure) was 18% (95% CI: 0.10–0.25), and the incidence rate of any treatment-emergent adverse events (TEAE) was 39% (95% CI: 0.09–0.68). The most common TEAE was somnolence, which had an incidence rate of 9% (95% CI: 0.07–0.12). And the incidence rate of mental or behavioral disorders was 12% (95% CI: 0.06–0.17).ConclusionOur systematic review and meta-analysis showed that BRV seemed to be safe and effective in the treatment of childhood epilepsy.

Publisher

Frontiers Media SA

Subject

Neurology (clinical),Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3